Wednesday, November 16, 2016
- 9:00AM-10:30AM
-
Abstract Number: 3149
“Early Use of Subcutaneous MTX Monotherapy Vs. MTX Oral or Combination Therapy Significantly Delays Time to Initiating Biologics in Early RA
Rheumatoid Arthritis – Clinical Aspects VI: Management of Early Rheumatoid Arthritis- 9:00AM-10:30AM
-
Abstract Number: 3128
A Longitudinal Dual Energy Computed Tomography Study on the Effect of Urate Lowering Therapies on the Reduction of Tophus Burden in Patients with Chronic Gout
Metabolic and Crystal Arthropathies II: Clinical Practice- 9:00AM-10:30AM
-
Abstract Number: 3156
Adding MRI of the Spine to the ASAS Classification Criteria for Axial Spondyloarthritis, Redundant or Beneficial? Results from the Spondyloarthritis Caught Early (SPACE)-Cohort
Spondylarthropathies and Psoriatic Arthritis – Clinical Aspects and Treatment V: Imaging of Spondyloarthritis- 9:00AM-10:30AM
-
Abstract Number: 3184
Antiphospoholipid Antibodies in Giant Cell Arteritis. What Can They Tell Us?
Vasculitis IV: Diagnosis and Assessment of Disease Activity- 9:00AM-10:30AM
-
Abstract Number: 3174
Apremilast Attenuates the Fibrogenic Phenotype of Dermal Fibroblasts from Patients with Systemic Sclerosis, Contributing to the Prevention of the Progression of Experimental Dermal Fibrosis
Systemic Sclerosis, Fibrosing Syndromes and Raynaud's – Pathogenesis, Animal Models and Genetics II- 9:00AM-10:30AM
-
Abstract Number: 3154
Assessing Bone Erosions in the Metatarsophalangeal Joints of Patients with Early Rheumatoid Arthritis: a Comparison Between MRI and Ultrasound
Rheumatoid Arthritis – Clinical Aspects VI: Management of Early Rheumatoid Arthritis- 9:00AM-10:30AM
-
Abstract Number: 3137
Assessing System-Level Performance Measures for Early Rheumatoid Arthritis in a Large Multicenter Cross-Country Prospective 8-Year Observational Cohort Study
Quality Measures and Quality of Care II- 9:00AM-10:30AM
-
Abstract Number: 3140
Assessment of American College of Rheumatology Gout Quality Measures at a University Practice Plan
Quality Measures and Quality of Care II- 9:00AM-10:30AM
-
Abstract Number: 3170
Association Between Insulin Resistance, Subclinical Artheriosclerosis and Activity/Damage Status in Systemic Lupus Erythematosus Patients
Systemic Lupus Erythematosus – Clinical Aspects and Treatment V: Damage and Morbidity- 9:00AM-10:30AM
-
Abstract Number: 3133
Association Between Quantitatively Measured Infrapatellar Fat Pad High Signal Intensity Alteration and Knee Structural and Symptomatic Abnormalities in Patients with Symptomatic Knee Osteoarthritis
Osteoarthritis – Clinical Aspect II: Treatment and Imaging- 9:00AM-10:30AM
-
Abstract Number: 3182
Attenuation of Fluorine-18-Fluorodeoxyglucose Uptake in Large Vessel Giant Cell Arteritis after Short-Term High-Dose Steroid Treatment – a Diagnostic Window of Opportunity
Vasculitis IV: Diagnosis and Assessment of Disease Activity- 9:00AM-10:30AM
-
Abstract Number: 3153
Automated Cell Phone Monitoring of Disease Activity and Medication Adherence in Early Rheumatoid Arthritis
Rheumatoid Arthritis – Clinical Aspects VI: Management of Early Rheumatoid Arthritis- 9:00AM-10:30AM
-
Abstract Number: 3139
Breaking the Cycle: Analyzing Preventable Hospital Admissions Due to Gout